NCT02900521

Brief Summary

The registry is the main objective exhaustive list of cases validated stroke brain on a geographical area defined to calculate an incidence.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,000

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Jan 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jan 2008Dec 2026

Study Start

First participant enrolled

January 1, 2008

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2016

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 14, 2016

Completed
10.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

May 26, 2023

Status Verified

May 1, 2023

Enrollment Period

8.6 years

First QC Date

August 22, 2016

Last Update Submit

May 25, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Type of stroke (ischemic or haemorrhagic)

    The type of stroke ischemic or haemorrhagic will be collected from physician diagnostic

    Inclusion

Secondary Outcomes (1)

  • Patient outcome

    Every year after the inclusion during 10 years

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Diagnostic validated for one of the following pathologies: * Ischemic stroke, * Non-traumatic intracranial hematoma * Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand

You may qualify if:

  • Diagnostic validated for one of the following pathologies:
  • Ischemic stroke,
  • Non-traumatic intracranial hematoma
  • Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand

You may not qualify if:

  • Age ≤ 15 years
  • Validated diagnosis (see below, § 4.2.2) of aneurysmal subarachnoid hemorrhage cerebrovascular
  • Diagnosis made before 1 January 2008
  • Unconfirmed diagnosis
  • Patient domiciled outside the previously defined area of residence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Brest

Brest, 29200, France

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeStrokeBrain IschemiaIntracranial HemorrhagesHemorrhagic StrokeCerebrovascular DisordersIschemic Attack, Transient

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Serge TIMSIT

    CHRU La Cavale Blanche - BREST - FRANCE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

September 14, 2016

Study Start

January 1, 2008

Primary Completion

August 1, 2016

Study Completion (Estimated)

December 1, 2026

Last Updated

May 26, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

Locations